Kymera Therapeutics Sets Nov. 23 Date for KT-621 Trial Results
Kymera Therapeutics says it will announce results from the Phase 2b BROADEN2 atopic dermatitis trial on Nov. 23, 2026.
Kymera Therapeutics says it will announce results from the Phase 2b BROADEN2 atopic dermatitis trial on Nov. 23, 2026.